Pro Medicus (OTCMKTS:PMCUF) Stock Price Down 5% – What’s Next?

Pro Medicus Limited (OTCMKTS:PMCUF) shares were down 5% during mid-day trading on Friday. The stock traded as low as $108.86 and last traded at $108.86. Approximately 300 shares changed hands during mid-day trading, a decline of 49% from the average daily volume of 583 shares. The stock had previously closed at $114.56.

Analysts Set New Price Targets

Separately, Jefferies Financial Group downgraded Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $155.00.

Pro Medicus Trading Down 4.6%

The company’s fifty day moving average price is $121.59 and its 200 day moving average price is $111.50.

Pro Medicus Company Profile

Pro Medicus Limited is an Australian medical technology company that develops software for medical imaging and healthcare organizations. Its primary product is the Visage enterprise imaging platform, which supports the storage, management, viewing and distribution of diagnostic images such as X-rays, CT scans and magnetic resonance images.

The company’s software is designed to help hospitals, radiology practices and other healthcare providers manage imaging workflows and enable clinicians to access diagnostic information across locations.